Stock Price Forecast

March 21, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading OmniAb Inc chart...

About the Company

We do not have any company description for OmniAb Inc at the moment.

Exchange

NASDAQ

$M

Total Revenue

7

Employees

$M

Market Capitalization

None

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OABI News

OmniAb Inc (NASDAQ: OABI) Analysts Expect It Could Climb 66.8% From Current Levels.

2d ago, source:

The trading price of OmniAb Inc (NASDAQ:OABI) closed lower on Friday, March 17, closing at $3.43, -2.83% lower than its previous close. Traders who pay close attention to intraday price movement ...

Thinking Of Buying OmniAb Inc (NASDAQ: OABI) Stock? Here’s What You Need To Know

6d ago, source:

OmniAb Inc (NASDAQ:OABI) price on Wednesday, March 15, rose 3.37% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.68. A look at the stock’s price ...

OmniAb: Legitimate Competition To AbCellera In Antibody Discovery

23d ago, source: Seeking Alpha

OmniAb recently completed its separation from Ligand Pharmaceuticals and is now a publicly traded independent company solely focused on antibody discovery partnerships. OmniAb utilizes what it ...

OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

13d ago, source: Morningstar

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, March 30, 2023 and will ...

OmniAb Inc (OABI) Stock: A Value Analysis

6d ago, source: newsheater

Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for OABI is 93.62M and currently, short sellers ...

10-K: LIGAND PHARMACEUTICALS INC

22d ago, source: MarketWatch

and OmniAb, Inc., a Delaware corporation and then wholly-owned subsidiary of our company (OmniAb), and Orwell Merger Sub Inc. (Merger Sub), pursuant to which New OmniAb combined with OmniAb ...

OmniAb to Participate in Three Upcoming Investor Conferences

16d ago, source: Yahoo News UK

EMERYVILLE, Calif., February 07, 2023--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences. SVB Securities Global ...

OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

13d ago, source: MarketWatch

EMERYVILLE, Calif., (BUSINESS WIRE) -- OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets ...

OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

13d ago, source: Yahoo Finance

EMERYVILLE, Calif., March 09, 2023--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...